FDA Adverse Event Injury Summary report: N

CINRATIO PT/INR TEST STRIPS

MDR report key: 4121352 · Received September 19, 2014

Report

Report Number
2027969-2014-00858
Event Type
Injury
Date Received
September 19, 2014
Date of Event
August 15, 2014
Report Date
August 25, 2014
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K092987
Removal / Correction Number
Z-0880, 0881, 0882-2015
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION PENDING.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT INRATIO RESULTS. RESULTS AS FOLLOWS: SEE SCANNED TABLE. TESTS PERFORMED SIDE BY SIDE ON (B)(6) 2014. THERAPEUTIC RANGE: 2.0-3.0. THE CUSTOMER SENT THE PATIENT TO THE HOSPITAL FOR CONFIRMATORY TESTING AFTER THE LAB RESULT ON (B)(6) 2014. THE PATIENT BELIEVED THAT THERE WAS AN ERROR IN THE LAB READING BECAUSE HE HAD NO UNUSUAL BRUISING OR BLEEDING. THE PATIENT TOLD THE FACILITY THAT HE HAD AN ABRASION ON (B)(6) 2014 THAT STOPPED BLEEDING ALMOST IMMEDIATELY; HE DID NOT FEEL THIS MATCHED WITH THE HIGH LAB INR VALUES. AFTER RECEIVING THE LAB RESULT ON (B)(6) 2014, THE PATIENT WAS ADMINISTERED VITAMIN K AT (B)(6) AND SENT HOME. THE PATIENT WAS NOT ADMITTED TO THE HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
583758 CINRATIO PT/INR TEST STRIPS PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 100139 345310

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention ALLOPURINOL 100MG/DAY| CYCLOBENZAPRINE 10MG 1-3X/DAY AS NEEDED.| INRATIO MONITOR, SERIAL # (B)(4)| LAB IS USING SIEMENS CA1500 INNOVEN REAGENTS| LISINOPRILL 10MG/DAY| WARFARIN SODIUM| LISINOPRILL 10MG/DAY| ALLOPURINOL 100MG/DAY| INRATIO MONITOR, SERIAL # (B)(4)| WARFARIN SODIUM| LAB IS USING SIEMENS CA1500 INNOVEN REAGENTS| CYCLOBENZAPRINE 10MG 1-3X/DAY AS NEEDED.